Rossari Biotech’s Q4 Growth Spree: Net Sales Surge 36%, Profit and Margins Climb

Rossari Biotech has given an electric performance for the quarter ended March 2025, reporting a stellar 35.96% year-on-year increase in standalone net sales to ₹426.65 crore, from ₹313.80 crore in the year-ago period. The specialty chemicals market leader's robust top-line growth is an indication of strong demand across its major segments despite the company operating in a competitive environment.

 

Key Highlights

Rossari Biotech's Q4 performance not only highlights its nimble growth engine but also lays the groundwork for growth in the specialty chemicals business to come.

 

Sources: Moneycontrol, NSE, Business Standard